Literature DB >> 22661521

Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension.

M Patricia George, Hunter C Champion, Mark T Gladwin, Karen A Norris, Alison Morris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661521      PMCID: PMC3373070          DOI: 10.1164/rccm.201204-0609ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.

Authors:  Leslie Spikes; Pranjali Dalvi; Ossama Tawfik; Haihua Gu; Norbert F Voelkel; Paul Cheney; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

2.  Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.

Authors:  Alison Morris; Matthew R Gingo; M Patricia George; Lorrie Lucht; Cathy Kessinger; Vikas Singh; Maria Hillenbrand; Michelle Busch; Deborah McMahon; Karen A Norris; Hunter C Champion; Mark T Gladwin; Yingze Zhang; Chad Steele; Frank C Sciurba
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

3.  Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension.

Authors:  Amie K Lund; Joann Lucero; Lindsay Herbert; Yushi Liu; Jay S Naik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-17       Impact factor: 5.464

4.  Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.

Authors:  M Patricia George; Alexandra Brower; Heather Kling; Tim Shipley; Jan Kristoff; Todd A Reinhart; Michael Murphey-Corb; Mark T Gladwin; Hunter C Champion; Alison Morris; Karen A Norris
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

5.  High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.

Authors:  Kristin E Mondy; John Gottdiener; E Turner Overton; Keith Henry; Tim Bush; Lois Conley; John Hammer; Charles C Carpenter; Erna Kojic; Pragna Patel; John T Brooks
Journal:  Clin Infect Dis       Date:  2010-12-09       Impact factor: 9.079

6.  Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.

Authors:  Navneet K Dhillon; Fang Li; Bing Xue; Ossama Tawfik; Susan Morgello; Shilpa Buch; Amy O'Brien Ladner
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-27       Impact factor: 6.914

7.  HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

Authors:  Bruno Degano; Mathilde Guillaume; Laurent Savale; David Montani; Xavier Jaïs; Azzedine Yaici; Jérôme Le Pavec; Marc Humbert; Gérald Simonneau; Olivier Sitbon
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

8.  Arteriopathy in macaques infected with simian immunodeficiency virus.

Authors:  L V Chalifoux; M A Simon; D R Pauley; J J MacKey; M S Wyand; D J Ringler
Journal:  Lab Invest       Date:  1992-09       Impact factor: 5.662

9.  Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles.

Authors:  J H Morse; R J Barst; S Itescu; E R Flaster; G Sinha; Y Zhang; M Fotino
Journal:  Am J Respir Crit Care Med       Date:  1996-04       Impact factor: 21.405

10.  Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.

Authors:  Joel Mermis; Haihua Gu; Bing Xue; Fang Li; Ossama Tawfik; Shilpa Buch; Sonja Bartolome; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Respir Res       Date:  2011-08-05
View more
  11 in total

1.  Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy.

Authors:  Joseph A Simonetti; Matthew R Gingo; Lawrence Kingsley; Cathy Kessinger; Lorrie Lucht; Gk Balasubramani; Joseph K Leader; Laurence Huang; Ruth M Greenblatt; John Dermand; Eric C Kleerup; Alison Morris
Journal:  J AIDS Clin Res       Date:  2014-11

Review 2.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 3.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

Review 4.  HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

Authors:  Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 5.  Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

Authors:  Christian Michael Perez; Quentin Felty
Journal:  Microvasc Res       Date:  2022-02-07       Impact factor: 3.514

Review 6.  Human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Christopher F Barnett; Priscilla Y Hsue
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

Review 7.  Non-infectious Pulmonary Diseases and HIV.

Authors:  M Triplette; K Crothers; E F Attia
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

8.  NADPH oxidase-mediated endothelial injury in HIV- and opioid-induced pulmonary arterial hypertension.

Authors:  Stuti Agarwal; Himanshu Sharma; Ling Chen; Navneet K Dhillon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-01       Impact factor: 5.464

9.  Extracellular Vesicle TGF-β1 Is Linked to Cardiopulmonary Dysfunction in Human Immunodeficiency Virus.

Authors:  Balaji Krishnamachary; Aatish Mahajan; Ashok Kumar; Stuti Agarwal; Aradhana Mohan; Ling Chen; Priscilla Y Hsue; Prabhakar Chalise; Alison Morris; Navneet K Dhillon
Journal:  Am J Respir Cell Mol Biol       Date:  2021-10       Impact factor: 6.914

Review 10.  Human immunodeficiency virus and pulmonary arterial hypertension.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.